FSDC insider transactions
FS Development Corp. (FSDC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for FSDC
- SEC Form 4 filed by Tuyen Ong4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 4 filed by Charles David Lubner4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 4 filed by Walter Strapps4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3 filed by Walter Strapps3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 4 filed by Precillia Redmond4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 4 filed by Scott Lauder4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3 filed by Brian Piekos3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3: Llc Associates, Lsv claimed ownership of 4,836,106 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3: Jean George claimed ownership of 4,836,106 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3: L.P. X, Fund Venture Atlas claimed ownership of 5,254,365 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3: P Jason Rhodes claimed ownership of 5,254,365 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3: Llc Advisors Orbimed claimed ownership of 5,826,224 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3: L Carl Gordon claimed ownership of 5,826,224 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3 filed by Marc Uknis3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3 filed by Precillia Redmond3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3 filed by Tuyen Ong3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3 filed by Patrick Jason Meyenburg3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3 filed by Charles David Lubner3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3: Scott Lauder claimed ownership of 104,622 units of Common Stock3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 3 filed by Gregg Beloff3 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 4: B. James Tananbaum was granted 1,500,000 units of Common Stock and converted 2,928,750 units into Common Stock4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)
- SEC Form 4: Llc Holdings, Development Fs converted 2,928,750 units into Common Stock and was granted 1,500,000 units of Common Stock4 - Gemini Therapeutics, Inc. /DE (0001816736) (Issuer)